A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene
Yíngyún Caì(National Institutes of Health), Luis Martínez‐Sobrido(Texas Biomedical Research Institute), Shuǐqìng Yú(National Institutes of Health), Tyler Brady(National Institutes of Health), Marisa St. Claire(National Institutes of Health), Juan Carlos de la Torre(Scripps Research Institute), Kurt Cooper(National Institutes of Health), Elena Postnikova(National Institutes of Health), Aitor Nogales(University of Rochester), Benson Yee Hin Cheng(University of Rochester), Jonathan Kurtz(National Institutes of Health), Randy Hart(National Institutes of Health), Masaharu Iwasaki(Scripps Research Institute), Chengjin Ye(Texas Biomedical Research Institute), Ricky Adams(National Institutes of Health), David X. Liu(National Institutes of Health), Jens H. Kuhn(National Institute of Allergy and Infectious Diseases)
Cited by 48
Related Papers
Animal models for COVID-19
|Nature|2020|877
Minimum Information about an Uncultivated Virus Genome (MIUViG)
|Nature Biotechnology|2018|787
Ebola virus disease
|Nature Reviews Disease Primers|2020|634
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
|The Lancet Microbe|2021|435